A Trial Comparing Docetaxel 75 mg/m2 (3w) Versus Docetaxel 50 mg/m2 (2w) in Combination With Darolutamide + ADT in mHSPC Patients

Clinical trial NCT05676203 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05676203
Sponsor: Jena University Hospital
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

Start date: 2023-05-16
Primary completion: 2025-07-03
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.